Abstract
According to WHO estimates, in 2010 there were 8.8 million new cases of tuberculosis (TB) and 1.5 million deaths. TB has been classically associated with poverty, overcrowding and malnutrition. Low income countries and deprived areas, within big cities in developed countries, present the highest TB incidences and TB mortality rates. These are the settings where immigration, important social inequalities, HIV infection and drug or alcohol abuse may coexist, all factors strongly associated with TB. In spite of the political, economical, research and community efforts, TB remains a major global health problem worldwide. Moreover, in this new century, new challenges such as multidrug-resistance extension, migration to big cities and the new treatments with anti-tumour necrosis alpha factor for inflammatory diseases have emerged and threaten the decreasing trend in the global number of TB cases in the last years. We must also be aware about the impact that smoking and diabetes pandemics may be having on the incidence of TB. The existence of a good TB Prevention and Control Program is essential to fight against TB. The coordination among clinicians, microbiologists, epidemiologists and others, and the link between surveillance, control and research should always be a priority for a TB Program. Each city and country should define their needs according to the epidemiological situation. Local TB control programs will have to adapt to any new challenge that arises in order to respond to the needs of their population.
Similar content being viewed by others
References
World Health Organization (2011) Global Tuberculosis Control. http://www.who.int/tb/publications/global_report/en/
Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE (2011) Time for zero deaths from tuberculosis. Lancet 378(9801):1449–1450
Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724–732
Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50(1):90–106
van Geuns HA, Meijer J, Styblo K (1975) Results of contact examination in Rotterdam, 1967–1969. Bull Int Union Tuberc 50(1):107–121
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–686
Advisory Council for the Elimination of Tuberculosis (ACET) (1999) Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 48(RR-9):1–13
Institute of Medicine (US) Committee on the Elimination of Tuberculosis in the United States (2000) Endling neglect: the elimination of tuberculosis in the United States, National Academy Press, Washington, DC
Orcau À, Caylà JA, Martínez JA (2011) Present epidemiology of tuberculosis. Prevention and control programs. Enferm Infecc Microbiol Clin Suppl 1:2–7
Houshian S, Poulsen S, Riegels-Nielsen P (2000) Bone and joint tuberculosis in Denmark: increase due to immigration. Acta Orthop Scand 71(3):312–315
Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL (2008) Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 31(1):99–105
Talbot JC, Bismil Q, Saralaya D, Newton DA, Frizzel RM, Shaw DL (2007) Musculoskeletal tuberculosis in Bradford—a 6-year review. Ann R Coll Surg Engl 89(4):405–409
García-Lechuz JM, Julve R, Alcala L, Ruíz-Serrano MJ, Muñoz P (2002) Espondilodiscitis tuberculosa o enfermedad de Pott: experiencia en un hospital general. Enferm Infecc Microbiol Clin 20(1):5–9
United Nations, Department of Economic and Social Affairs, Population Division (2009) Trends in International Migrant Stock: the 2008 revision (United Nations database, POP/DB/MIG/Stock/Rev.2008)
Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB (1994) Tuberculosis control in Europe and international migration. Eur Respir J 7:1545–1553
Tuberculosis Surveillance Report in Europe 2009. European Centre for Disease Prevention and Control (ECDC) and WHO regional office for Europe
Marin M, Moreno R, Gil M, Bueso MJ, Romeu MA, Gonzalez F (2010) Impacto de la inmigración desde Rumanía en la tuberculosis de un area mediterránea. Enf Emerg 12:115–120
Cayla JA, Orcau A Control of tuberculosis in large cities in developed countries: an organisational problem. BMC Medicine (in press)
Bothamley GH, Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, Woodhead MA, Watson JP, Chapman ALN. Tuberculosis in UK cities: workload and effectiveness of TB control programmes. BMC Public Health (in press)
Tuberculosis in the UK. Report on tuberculosis surveillance in the UK 2010 Health Protection Agency
Gatell JM, Zulaica D, Del Romero J (2010) Cómo promover y facilitar el diagnóstico precoz de la infección por el VIH-1. Enf Emerg 12:121–124
Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545–550
Getahun H, Gunneberg C, Granich R, Nunn P (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50(Suppl 3):S201–S207
Decker CF, Masur H (1994) Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS 8:11–20
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT et al (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 317:185–191
Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R (1997) A cohort study in Bordeaux, France, 1988–1994. The Groupe d’Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol 15:293–300
Pablos-Méndez A, Sterling TR, Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276:1223–1228
García de Olalla P, Martínez-González MA, Caylà JA, Jansà JM, Iglesias B, Guerrero R, Marco A, Gatell JM, Ocaña I, Barcelona AIDS–TB Study Group (2002) Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 6:1051–1057
Leonard MK, Larsen N, Drechsler H et al (2002) Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991–2000. Clin Infect Dis 34:1002–1007
Thseng SH, Shyong-Jiang DD, Hoi HS, Lo HY, Hwang KP (2009) Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993–2006. Emerg Infect Dis 15:332–334
Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC (2003) Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 17:2615–2622
Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320(9):545–550
Deiss RG, Rodwell TC, Garfein RS (2009) Tuberculosis and illicit drug use: review and update. Clin Infect Dis 48(1):72–82
European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC. http://www.ecdc.europa.eu/en/publications/Publications/111012_Guidance_ECDC-EMCDDA.pdf)
WHO Report on the global tobacco epidemic (2011). http://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf
Shafey O, Eriksen M, Ross H, Mackay J (2009) El atlas del tabaco. Sociedad Americana del Cáncer 3:18–21
Ministerio de Sanidad. Encuesta Nacional de Salud de España (1987–2006).http://msps.es/estadEstudios/estadisticas/encuestaNacional/encuesta2006.htm
Leung CM, Leung KC, Hon KE, Kong AY (2009) Fighting tobacco smoking—a difficult but not impossible battle. Int J Environ Res Public Health 6:69–83
World Health Organization (2007) The Union against tuberculosis and lung diseases. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics; WHO/HTM/TB/2007.390:21–23
Alcaide J, Altet MN, Plans P, Parrón I, Folguera L, Saltó E, Domínguez A, Pardell H, Salleras L (1996) Cigarette smoking as a risk factor for tuberculosis in young adults: a case–control study. Tuber Lung Dis 77:112–116
Leng CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC (2004) Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 170:1027–1033
Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S, Manneh K, Adegbola A, Aaby P, Bah-Sow O, Bennett S, McAdam K (2005) Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol 34:914–923
Lin HH, Ezzati M, Chang HY, Murray M (2009) Association between tobacco smoking and active tuberculosis in Taiwan. Prospective cohort study. Am J Respir Crit Care Med 180:475–480
Jee SH, Golub JE, Jo J, LlS Park, Ohrr H, Samet JM (2009) Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 170:1478–1485
Slama K, Chiang CY, Enarson DA, Hassmiller Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11:1049–1061
Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4(1):e20
Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 167:335–342
den Boon S, Verver S, Marais BJ, Enarson DA, Lombard CJ, Bateman ED, Irusen E, Jithoo A, Gie RP, Borgdorff MW, Beyers N (2007) Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 119(4):734–739
Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, Law WS, Chan CK, Chang KC, Au KF (2010) Passive smoking and tuberculosis. Arch Intern Med 170(3):287–292
Altet MN, Alcaide J, Plans P, Taberner JL, Saltó E, Ll Folguera et al (1996) Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case–control study. Tub Lung Dis 77:537–544
Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK (2005) Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child 90(6):624–628
World Health Organization/International Union Against Tuberculosis and Lung Disease (2007) Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world: report no. 4. Geneva, Switzerland: WHO. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
Sharma SK, Mohan A (2006) Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:162–272
World Health Organization (2011) Guidelines for the programmatic management of drug-resistant tuberculosis. http://www.who.int/tb/challenges/mdr/programmatic_guidelines_for_mdrtb/en/index.html
Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. Report 2011. http://www.who.int/tb/features_archive/world_tb_day_mdr_report_2011/en/
La tuberculosi a Barcelona. Informe 2009. http://www.aspb.es/quefem/docs/Tuberculosi_2009.pdf
Chan ED, Iseman MD (2008) Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 21:587–595
Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Caylà J, Domínguez JA, García JM, Vidal R (2008) Diagnóstico y tratamiento de la tuberculosis. Normativa SEPAR. Arch Bronconeumol 44:551–566
Sarkar S, Suresh MR (2011) An overview of tuberculosis chemotherapy—a literature review. J Pharm Pharmaceut Sci 14:148–161
Singla R, Caminero JA, Jaswal A, Singla N, Gupta S, Bali RK, Behera D (2011) Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure in India. Eur Respir J (Epub ahead of print)
Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, van Soonlingen D (2010) Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrobiol Agents 35:524–526
Our motto. Health News. February 1914;30:table of contents. Monthly Bulletin: New York State Department of Health
Reichman LB (1997) Defending the Public’s health against tuberculosis. JAMA 278:865–867
Reichman LB (1991) The U shaped curve of concern. Am Rev Resp Dis 148:741–742
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA (1995) Tuberculosis in New York city—turning the tide. N Engl J Med 333(4):229–233
New York City, Department of Health and Mental Hygiene (2009) Annual Summary 2008: New York city is stopping TB. New York, NY. http://www.nyc.gov/html/doh/downloads/pdf/tb/tb_annualsummary08.pdf
Marco A, Caylà JA, Serra M, Pedro R, Sanrama C, Guerrero R, Ribot N (1998) Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 4:967–971
Ospina JE, Orcau A, Millet JP, Caylà JA, Casals M, Rius C, Sanchez F (2009) Effectiveness of community health workers for the control of tuberculosis. Int J Tubec Lung Dis 13(12) suppl 1 (Abstract book. 40th World Conference on Lung Health of the IUATL)
Rodrigo T, Caylà JA, Galdós-Tangüis H, García de Olalla P, Brugal MT, Jansà JM (2001) Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 5:432–440
Gillman A, Berggren I, Bergström SE, Wahlgren H, Bennet R (2008) Primary tuberculosis infection in 35 children at a Swedish day care center. Pediatr Infect Dis J 27:1078–1082
World Health Organization (2011) Collaborative framework for care and control of tuberculosis and diabetes. http://whqlibdoc.who.int/publications/2011/9789241502252_eng.pdf
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Millet, JP., Moreno, A., Fina, L. et al. Factors that influence current tuberculosis epidemiology. Eur Spine J 22 (Suppl 4), 539–548 (2013). https://doi.org/10.1007/s00586-012-2334-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-012-2334-8